Preclinical Research

Berlex buys CompleGen system

Berlex buys CompleGen system

Genetics-based drug discovery company CompleGen is to supply Berlex
Biosciences, a US affiliate of German company Schering, with a high
throughput assay system for discovery of compounds active against a
novel target identified by...

EU R&D keeps active

EU R&D keeps active

There has been 'unprecedented development' in terms of the
Community's research policy in the last year claims the European
Commission's 2002 annual report on technological research and
development (RTD) in 2001.

RNAi tools

RNAi tools

Dharmacon, a US supplier of RNA and RNA-interference research
products, announced today it has launched Cell Cycle siARRAY, a
collection of ready-to-use siRNA duplexes designed to knock down
112 genes involved in cell cycle regulation.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...

Forging genomics

Forging genomics

Biotechnology service group SeqWright has entered into an agreement
with Fisher Scientific that combines SeqWright's services with
Fisher's scientific research products.

Follow us

Products

View more

Webinars